YILING PHARMACEUTICAL
00260316.890.59% ( -0.10 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: YILING PHARMACEUTICAL(002603) the Revenue is 2.44 B (+3.46%);the EBIT is 492.24 M (+17.64%);the EPS is 0.245 (+25.42%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
2.44B3.46%
----
----
EBIT
0.49B17.64%
----
----
EPS
0.244725.42%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf